Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing YOUNG: Perspectives in the treatment of breast cancer: 1976. (0.09 sec) 

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, …


… , GR Blumenschein, CK Tashima, MA Burgess … - CA A Cancer Journal … - interscience.wiley.com
One hundred and five patients with metastatic breast cancer were treated with 5-fluorouracil,
Adriamycin, cyclophosphamide and BCG (FAC-BCG). The results were compared to those observed
in a group of 44 patients treated with FAC chemotherapy alone. Although the overall ...
Cited by 64 - Related articles - All 4 versions

Combination chemotherapy for advanced breast cancer utilizing vincristine, …


JM Rainey, SE Jones, SE Salmon - CA A Cancer Journal for Clinicians - interscience.wiley.com
Thirty-two patients with advanced breast cancer were treated with a combination of vincristine
(1 mg/m 2 , not exceeding 2 mg, administered intravenously on day 1), adriamycin (40 mg/m
2 administered intravenously on day 1), and cyclophosphamide (200 mg/m 2 ...
Cited by 27 - Related articles - All 2 versions

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without …


RE Lloyd, SE Jones, SE Salmon - CA A Cancer Journal for Clinicians - interscience.wiley.com
We treated 56 women with advanced metastatic breast cancer who had not received prior chemotherapy
in a comparative trial of cytotoxic chemotherapy with low-dose adriamycin plus cyclophosphamide
alone or in combination with the androgenic steroid calusterone. The response rate to ...
Cited by 22 - Related articles - All 2 versions

A phase I/II investigation of trioxifene mesylate in advanced breast cancer: Clinical …


RS Witte, B Pruitt, DC Tormey, S Moss, DP … - CA A Cancer Journal … - interscience.wiley.com
Tamoxifen and trioxifene are antiestrogens that appear to have different endocrine effects when
tested in rats. Whereas tamoxifen has considerable clinical activity, trioxifene is a new antiestrogen
with undefined clinical activity. Thirty-six patients were treated with graded doses of ...
Cited by 11 - Related articles - All 3 versions

A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin …


K Inoue, M Ogawa, J Inagaki, N Horikoshi, H … - Cancer chemotherapy …, 1984 - Springer
Summary. A prospective randomized trial was conducted comparing the clinical response of
60 patients with advanced breast cancer to a combination of adriamycin, cyclophospham-
ide, and oral ftorafur (ACF), or to a combination of ACF plus methotrexate (ACFM). The ...
Cited by 5 - Related articles - All 5 versions

The importance of treatment sequence in advanced and metastatic carcinoma of …


AE Awrich, ME Peetz, HS Moseley, E Keenan, … - Seminars in Surgical … - interscience.wiley.com
From 1965 to the present, 287 patients with advanced and metastatic carcinoma of the breast
have been treated according to a uniform philosophy of sequential therapy. Surgical castration
was the initial procedure for premenopausal women and for postmenopausal women with ...
Cited by 4 - Related articles - All 2 versions

[CITATION] Other alkylating agents


SD Reich - Cancer and Chemotherapy, 1981 - Academic Press
Cited by 1 - Related articles

[CITATION] The Ms. guide to a woman's health: the most up-to-date guide to a woman's health …


CW Cooke, S Dworkin - 1979 - Doubleday Books
Related articles

[PDF] POST GRADUATE TRAINING


V PROFESSORSHIPS - fccc.edu
1970 - 1988 Consultant in Oncology, Walter Reed Army Hospital Washington, DC 1973 - 1976
Clinical Assistant Professor of Medicine, Georgetown University School of Medicine,
Washington, DC 1976 - 1987 Clinical Associate Professor of Medicine, Georgetown ...
Related articles - View as HTML - All 5 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google